Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Chemotherapy

Courtney D. DiNardo; Daniel A. Pollyea

doi:10.1200/JCO.21.02762

Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Chemotherapy

Courtney D. DiNardo, Daniel A. Pollyea

Leukemia

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	811-813
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	40
Issue number	8
DOIs	https://doi.org/10.1200/JCO.21.02762
State	Published - Mar 10 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.21.02762

Cite this

@article{b895e995f1534f1491e98266ff936248,

title = "Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Chemotherapy",

author = "DiNardo, {Courtney D.} and Pollyea, {Daniel A.}",

note = "Funding Information: C.D.D. was supported by a V Foundation Lloyd Family Clinical Scholar and LLS Scholar in Clinical Research Award. D.A.P. was supported by the Robert H. Allen MD Chair of Hematology Research and the LLS Scholar in Clinical Research Award.",

year = "2022",

month = mar,

day = "10",

doi = "10.1200/JCO.21.02762",

language = "English (US)",

volume = "40",

pages = "811--813",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "8",

}

TY - JOUR

T1 - Beyond Survival

T2 - The US Food and Drug Administration Confirms Surrogate End Points for Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Chemotherapy

AU - DiNardo, Courtney D.

AU - Pollyea, Daniel A.

N1 - Funding Information: C.D.D. was supported by a V Foundation Lloyd Family Clinical Scholar and LLS Scholar in Clinical Research Award. D.A.P. was supported by the Robert H. Allen MD Chair of Hematology Research and the LLS Scholar in Clinical Research Award.

PY - 2022/3/10

Y1 - 2022/3/10

UR - http://www.scopus.com/inward/record.url?scp=85125964771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125964771&partnerID=8YFLogxK

U2 - 10.1200/JCO.21.02762

DO - 10.1200/JCO.21.02762

M3 - Review article

C2 - 35007124

AN - SCOPUS:85125964771

SN - 0732-183X

VL - 40

SP - 811

EP - 813

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 8

ER -

Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Chemotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this